【4551】鳥居薬品
医薬品。親会社はJT。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024.12 | 2024/10/31 | Q3予 | 61,200 | ↑ | +0.8% | +4.4% | 6,700 | ↑ | +6.3% | +15.5% | 6,800 | ↑ | +6.3% | +17.2% | 5,100 | ↑ | +6.3% | +8.5% |
2024.12 | 2024/07/31 | Q2予 | 60,700 | ↑ | +3.6% | +3.6% | 6,300 | ↑ | +8.6% | +8.6% | 6,400 | ↑ | +10.3% | +10.3% | 4,800 | ↑ | +2.1% | +2.1% |
2024.12 | 2024/04/26 | Q1予 | 58,600 | → | 0.0% | 0.0% | 5,800 | → | 0.0% | 0.0% | 5,800 | → | 0.0% | 0.0% | 4,700 | → | 0.0% | 0.0% |
2024.12 | 2024/02/09 | 当初予 | 58,600 | - | - | - | 5,800 | - | - | - | 5,800 | - | - | - | 4,700 | - | - | - |
2023.12 | 2024/02/09 | 実 | 54,638 | ↑ | +1.2% | +7.3% | 5,035 | ↑ | +11.9% | +22.8% | 5,307 | ↑ | +12.9% | +20.6% | 4,119 | ↑ | +21.1% | +32.9% |
2023.12 | 2023/10/31 | Q3予 | 54,000 | ↑ | +2.5% | +6.1% | 4,500 | ↑ | +9.8% | +9.8% | 4,700 | ↑ | +6.8% | +6.8% | 3,400 | ↑ | +9.7% | +9.7% |
2023.12 | 2023/07/31 | Q2予 | 52,700 | ↑ | +3.5% | +3.5% | 4,100 | → | 0.0% | 0.0% | 4,400 | ↑ | +7.3% | 0.0% | 3,100 | → | 0.0% | 0.0% |
2023.12 | 2023/04/28 | Q1予 | 50,900 | → | 0.0% | 0.0% | 4,100 | → | 0.0% | 0.0% | 4,100 | ↓ | -6.8% | -6.8% | 3,100 | → | 0.0% | 0.0% |
2023.12 | 2023/02/10 | 当初予 | 50,900 | - | - | - | 4,100 | - | - | - | 4,400 | - | - | - | 3,100 | - | - | - |
2022.12 | 2023/02/10 | 実 | 48,896 | ↓ | -0.6% | +1.4% | 5,540 | ↓ | -7.7% | +6.5% | 5,537 | ↓ | -7.7% | +2.5% | 3,944 | ↓ | -8.3% | +3.8% |
2022.12 | 2022/10/31 | Q3予 | 49,200 | ↓ | -1.2% | +2.1% | 6,000 | ↓ | -3.2% | +15.4% | 6,000 | ↓ | -1.6% | +11.1% | 4,300 | ↓ | -2.3% | +13.2% |
2022.12 | 2022/07/29 | Q2予 | 49,800 | ↑ | +3.3% | +3.3% | 6,200 | ↑ | +19.2% | +19.2% | 6,100 | ↑ | +17.3% | +13.0% | 4,400 | ↑ | +15.8% | +15.8% |
2022.12 | 2022/04/28 | Q1予 | 48,200 | → | 0.0% | 0.0% | 5,200 | → | 0.0% | 0.0% | 5,200 | ↓ | -3.7% | -3.7% | 3,800 | → | 0.0% | 0.0% |
2022.12 | 2022/02/10 | 当初予 | 48,200 | - | - | - | 5,200 | - | - | - | 5,400 | - | - | - | 3,800 | - | - | - |
2021.12 | 2022/02/10 | 実 | 46,987 | ↑ | +0.2% | +2.8% | 4,656 | ↑ | +3.5% | +22.5% | 4,847 | ↑ | +3.1% | +18.2% | 3,374 | ↑ | +5.4% | +25.0% |
2021.12 | 2021/10/29 | Q3予 | 46,900 | ↑ | +1.1% | +2.6% | 4,500 | ↑ | +12.5% | +18.4% | 4,700 | ↑ | +11.9% | +14.6% | 3,200 | ↑ | +14.3% | +18.5% |
2021.12 | 2021/07/30 | Q2予 | 46,400 | ↑ | +1.5% | +1.5% | 4,000 | ↑ | +5.3% | +5.3% | 4,200 | ↑ | +2.4% | +2.4% | 2,800 | ↑ | +3.7% | +3.7% |
2021.12 | 2021/04/28 | Q1予 | 45,700 | → | 0.0% | 0.0% | 3,800 | → | 0.0% | 0.0% | 4,100 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% |
2021.12 | 2021/02/04 | 当初予 | 45,700 | - | - | - | 3,800 | - | - | - | 4,100 | - | - | - | 2,700 | - | - | - |
2020.12 | 2021/02/04 | 実 | 41,700 | ↑ | +1.7% | +0.2% | 4,738 | ↑ | +12.8% | +57.9% | 4,971 | ↑ | +10.5% | +50.6% | 3,495 | ↑ | +12.7% | +66.4% |
2020.12 | 2020/10/30 | Q3予 | 41,000 | ↑ | +0.2% | -1.4% | 4,200 | ↑ | +13.5% | +40.0% | 4,500 | ↑ | +12.5% | +36.4% | 3,100 | ↑ | +19.2% | +47.6% |
2020.12 | 2020/07/31 | Q2予 | 40,900 | ↓ | -1.7% | -1.7% | 3,700 | ↑ | +23.3% | +23.3% | 4,000 | ↑ | +21.2% | +21.2% | 2,600 | ↑ | +23.8% | +23.8% |
2020.12 | 2020/04/30 | Q1予 | 41,600 | → | 0.0% | 0.0% | 3,000 | → | 0.0% | 0.0% | 3,300 | → | 0.0% | 0.0% | 2,100 | → | 0.0% | 0.0% |
2020.12 | 2020/02/06 | 当初予 | 41,600 | - | - | - | 3,000 | - | - | - | 3,300 | - | - | - | 2,100 | - | - | - |
2019.12 | 2020/02/06 | 実 | 42,998 | ↑ | +0.0% | +13.2% | 1,430 | → | 0.0% | +144.7% | 1,691 | ↑ | +0.1% | +154.5% | 27,367 | ↑ | +0.0% | +21.6% |
2019.12 | 2020/01/20 | 修正予 | 42,990 | ↑ | +0.7% | +13.1% | 1,430 | ↑ | +104.3% | +144.7% | 1,690 | ↑ | +69.0% | +154.5% | 27,360 | ↑ | +6.5% | +21.6% |
2019.12 | 2019/10/31 | Q3予 | 42,700 | ↑ | +4.7% | +12.4% | 700 | ↑ | +200.0% | +121.9% | 1,000 | ↑ | +350.0% | +132.3% | 25,700 | ↑ | +4.0% | +14.2% |
2019.12 | 2019/07/31 | Q2予 | 40,800 | ↑ | +7.4% | +7.4% | -700 | ↑ | +78.1% | +78.1% | -400 | ↑ | +87.1% | +87.1% | 24,700 | ↑ | +9.8% | +9.8% |
2019.12 | 2019/04/25 | Q1予 | 38,000 | → | 0.0% | 0.0% | -3,200 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | 22,500 | → | 0.0% | 0.0% |
2019.12 | 2019/02/06 | 当初予 | 38,000 | - | - | - | -3,200 | - | - | - | -3,100 | - | - | - | 22,500 | - | - | - |
2018.12 | 2019/02/06 | 実 | 62,551 | ↑ | +0.9% | +3.0% | 4,951 | ↑ | +20.8% | +41.5% | 5,080 | ↑ | +21.0% | +41.1% | 1,164 | ↓ | -61.2% | -55.2% |
2018.12 | 2018/10/31 | Q3予 | 62,000 | ↑ | +0.8% | +2.1% | 4,100 | ↑ | +17.1% | +17.1% | 4,200 | ↑ | +16.7% | +16.7% | 3,000 | ↑ | +15.4% | +15.4% |
2018.12 | 2018/07/30 | Q2予 | 61,500 | ↑ | +1.3% | +1.3% | 3,500 | → | 0.0% | 0.0% | 3,600 | → | 0.0% | 0.0% | 2,600 | → | 0.0% | 0.0% |
2018.12 | 2018/04/26 | Q1予 | 60,700 | → | 0.0% | 0.0% | - | - | - | - | 3,600 | → | 0.0% | 0.0% | 2,600 | → | 0.0% | 0.0% |
2018.12 | 2018/02/06 | 当初予 | 60,700 | - | - | - | 3,500 | - | - | - | 3,600 | - | - | - | 2,600 | - | - | - |
2017.12 | 2018/02/06 | 実 | 64,135 | ↑ | +0.0% | -0.6% | 6,281 | ↑ | +0.0% | +18.5% | 6,403 | ↑ | +0.0% | +18.6% | 4,718 | ↑ | +0.2% | +21.0% |
2017.12 | 2018/01/22 | 修正予 | 64,130 | ↑ | +1.6% | -0.6% | 6,280 | ↑ | +25.6% | +18.5% | 6,400 | ↑ | +25.5% | +18.5% | 4,710 | ↑ | +23.9% | +20.8% |
2017.12 | 2017/10/26 | Q3予 | 63,100 | → | 0.0% | -2.2% | 5,000 | ↓ | -5.7% | -5.7% | 5,100 | ↓ | -5.6% | -5.6% | 3,800 | ↓ | -2.6% | -2.6% |
2017.12 | 2017/07/27 | Q2予 | 63,100 | ↓ | -2.2% | -2.2% | 5,300 | → | 0.0% | 0.0% | 5,400 | → | 0.0% | 0.0% | 3,900 | → | 0.0% | 0.0% |
2017.12 | 2017/04/27 | Q1予 | 64,500 | → | 0.0% | 0.0% | 5,300 | → | 0.0% | 0.0% | 5,400 | → | 0.0% | 0.0% | 3,900 | → | 0.0% | 0.0% |
2017.12 | 2017/02/02 | 当初予 | 64,500 | - | - | - | 5,300 | - | - | - | 5,400 | - | - | - | 3,900 | - | - | - |
2016.12 | 2017/02/02 | 実 | 60,206 | ↑ | +0.0% | -1.3% | 3,819 | ↑ | +0.2% | +15.7% | 3,999 | ↑ | +0.2% | +17.6% | 2,839 | ↑ | +2.5% | +23.4% |
2016.12 | 2017/01/23 | 修正予 | 60,200 | ↓ | -0.5% | -1.3% | 3,810 | ↑ | +27.0% | +15.5% | 3,990 | ↑ | +28.7% | +17.4% | 2,770 | ↑ | +31.9% | +20.4% |
2016.12 | 2016/10/28 | Q3予 | 60,500 | ↓ | -0.8% | -0.8% | 3,000 | → | 0.0% | -9.1% | 3,100 | → | 0.0% | -8.8% | 2,100 | ↑ | +5.0% | -8.7% |
2016.12 | 2016/07/28 | Q2予 | 61,000 | → | 0.0% | 0.0% | 3,000 | ↓ | -9.1% | -9.1% | 3,100 | ↓ | -8.8% | -8.8% | 2,000 | ↓ | -13.0% | -13.0% |
2016.12 | 2016/04/27 | Q1予 | 61,000 | → | 0.0% | 0.0% | 3,300 | → | 0.0% | 0.0% | 3,400 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
2016.12 | 2016/02/03 | 当初予 | 61,000 | - | - | - | 3,300 | - | - | - | 3,400 | - | - | - | 2,300 | - | - | - |
2015.12 | 2016/02/03 | 実 | 62,378 | ↑ | +0.0% | -1.0% | 4,919 | ↑ | +0.2% | -10.6% | 5,135 | ↑ | +0.1% | -8.3% | 3,527 | ↑ | +0.2% | +0.8% |
2015.12 | 2016/01/18 | 修正予 | 62,370 | ↑ | +1.7% | -1.0% | 4,910 | ↑ | +22.8% | -10.7% | 5,130 | ↑ | +22.1% | -8.4% | 3,520 | ↑ | +35.4% | +0.6% |
2015.12 | 2015/10/30 | Q3予 | 61,300 | ↓ | -1.4% | -2.7% | 4,000 | ↓ | -7.0% | -27.3% | 4,200 | ↓ | -4.5% | -25.0% | 2,600 | ↓ | -7.1% | -25.7% |
2015.12 | 2015/07/29 | Q2予 | 62,200 | ↓ | -1.3% | -1.3% | 4,300 | ↓ | -21.8% | -21.8% | 4,400 | ↓ | -21.4% | -21.4% | 2,800 | ↓ | -20.0% | -20.0% |
2015.12 | 2015/04/28 | Q1予 | 63,000 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% | 5,600 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% |
2015.12 | 2015/02/04 | 当初予 | 63,000 | - | - | - | 5,500 | - | - | - | 5,600 | - | - | - | 3,500 | - | - | - |
2014.12 | 2015/02/04 | 実 | 43,504 | ↑ | +0.0% | +1.4% | 4,032 | ↑ | +15.2% | +49.3% | 4,142 | ↑ | +15.1% | +47.9% | 2,419 | ↑ | +21.0% | +51.2% |
2014.12 | 2014/10/30 | Q2予 | 43,500 | ↑ | +1.4% | +1.4% | 3,500 | ↑ | +29.6% | +29.6% | 3,600 | ↑ | +28.6% | +28.6% | 2,000 | ↑ | +25.0% | +25.0% |
2014.12 | 2014/07/30 | Q1予 | 42,900 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% | 2,800 | → | 0.0% | 0.0% | 1,600 | → | 0.0% | 0.0% |
2014.12 | 2014/04/24 | 当初予 | 42,900 | - | - | - | 2,700 | - | - | - | 2,800 | - | - | - | 1,600 | - | - | - |
2014.03 | 2014/04/24 | 実 | 58,109 | ↑ | +0.0% | +0.0% | 4,987 | ↑ | +0.1% | +0.1% | 5,124 | ↑ | +0.1% | +0.1% | 3,352 | ↑ | +0.1% | +0.1% |
2014.03 | 2014/04/14 | 当初予 | 58,100 | - | - | - | 4,980 | - | - | - | 5,120 | - | - | - | 3,350 | - | - | - |